J Psychiatr Pract. 2021 Jan 21;27(1):23-32. doi: 10.1097/PRA.0000000000000525.
Evidence indicates that autism spectrum disorder (ASD) is underidentified in populations with psychosis, but that clinical presentations of comorbid ASD and psychosis (ASD-P) and specific treatment needs that may relate to this group are not well understood. In fact, recent studies of ASD in first-episode psychosis suggest that there may be a specific clinical presentation of ASD-P. In response, the Cambridgeshire and Peterborough Early Intervention in Psychosis (EIP) service in the UK implemented and evaluated a 3-step ASD screening and diagnostic protocol, using the Autism Spectrum Disorder in Adults Screening Questionnaire (ASDASQ), case note review, and the Autism Diagnostic Observation Schedule (ADOS-2) and the Childhood Autism Spectrum Test (CAST). As a quality improvement project, the evaluation aimed to (1) establish the prevalence of patients with ASD-P, (2) describe characteristics of the clinical presentation of ASD-P and compare them to those of patients suffering from psychosis but no ASD, and (3) determine any differences in treatment between psychosis patients with and without ASD. Notably, at least 9% of the EIP service caseload met the criteria for a diagnosis of ASD-P, with half identified via the implementation of this protocol. The patients with ASD-P had specific clinical presentations and treatment needs that differed from those of patients with psychosis but no ASD. Thus, the findings from this study supported existing evidence concerning the underdetection of ASD in EIP populations. Our findings also added to emerging evidence for a clinical presentation of ASD-P with specific treatment needs. Our protocol has now been established as routine practice, and its implementation has improved the detection and treatment of patients with ASD-P within our EIP service.
有证据表明,自闭症谱系障碍(ASD)在精神病患者中未被充分识别,但 ASD 与精神病共病(ASD-P)的临床表现以及可能与该群体相关的特定治疗需求尚未得到很好的理解。事实上,最近对首发精神病患者中 ASD 的研究表明,ASD-P 可能存在特定的临床表现。有鉴于此,英国剑桥和彼得伯勒早期精神病干预(EIP)服务实施并评估了一个三步 ASD 筛查和诊断方案,使用成人 ASD 筛查问卷(ASDASQ)、病历回顾以及自闭症诊断观察量表(ADOS-2)和儿童自闭症谱系测试(CAST)。作为一项质量改进项目,该评估旨在:(1)确定 ASD-P 患者的患病率;(2)描述 ASD-P 的临床表现特征,并将其与没有 ASD 的精神病患者进行比较;(3)确定 ASD 患者与非 ASD 患者之间的治疗差异。值得注意的是,EIP 服务的至少 9%的患者符合 ASD-P 的诊断标准,其中一半是通过实施该方案确定的。ASD-P 患者具有与没有 ASD 的精神病患者不同的特定临床表现和治疗需求。因此,这项研究的结果支持了关于在 EIP 人群中 ASD 检测不足的现有证据。我们的发现也为 ASD-P 的特定治疗需求的临床表现提供了新的证据。我们的方案现已成为常规实践,其实施提高了我们的 EIP 服务中 ASD-P 患者的检出率和治疗率。